Filter News
Area of Research
News Topics
- (-) Biomedical (3)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (2)
- Bioenergy (2)
- Biology (2)
- Chemical Sciences (1)
- Clean Water (1)
- Composites (1)
- Computer Science (6)
- Coronavirus (2)
- Energy Storage (2)
- Environment (3)
- Fusion (1)
- High-Performance Computing (1)
- Machine Learning (1)
- Materials (2)
- Materials Science (6)
- Microscopy (1)
- Nanotechnology (2)
- Neutron Science (22)
- Nuclear Energy (1)
- Physics (3)
- Quantum Computing (1)
- Quantum Science (2)
- Transportation (1)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.